Other official information and services: www.belgium.be
Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2014C027 Product name: CANAGLIFLOZINE.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
- Application number:
- 2014C/027
- Type:
- Certificate
- SPC type:
- Medical
- Basic patent number:
- 047713144
- Status:
- Active
- Publication number:
- 2014C027
- 1rst applicant's nationality:
- Procedural language:
- Dutch
Paediatric extension
- SPC Extension filing date:
- 25/03/2026
- SPC Extension agent/owner name:
- DE CLERCQ Ann
- SPC Extension status:
- Open
- SPC Extension grant date:
- SPC Extension Rejection Date:
Marketing authorization
- Marketing authorization number:
- EU/1/13/884
- Marketing authorization type:
- National/EU
- Designates country:
- No
- Marketing authorization date:
- 19/11/2013
- Marketing authorization status:
- Accepted
- Marketing authorization country:
- Belgium (BE)
Dates
- Filing date:
- 29/04/2014
- First marketing authorization date:
- 19/11/2013
- Grant date:
- 14/12/2023
- Activation date:
- 30/07/2024
- BE Publication date:
- 08/06/2018
- Lapsed date:
- Expiration date (if granted and all annual fees paid):
- Basic SPC Expiration (if granted and all annual fees paid):
- 19/11/2028
- SPC/SPC Extension Expiration (if granted and all annual fees paid):
- 19/05/2029
- Rejection date:
- Withdrawal date:
Applicant
1
- Name:
- Mitsubishi Tanabe Pharma Corporation
- Legal Form:
- Kabushiki kaisha
- From:
- 15/06/2016
- Address:
- 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505, Japan (JP)
- To:
2
- Name:
- Mitsubishi Tanabe Pharma Corporation.
- Legal Form:
- From:
- 29/04/2014
- Address:
- 2-6-18 Kitahama Chuo-ku Osaka-shi, Osaka 541-8505, Japan (JP)
- To:
- 15/06/2016
Agent
- Name:
- DE CLERCQ Ann
- Legal Form:
- From:
- 29/04/2014
- Address:
- Ed. Gevaertdreef 10a, 9830, ST MARTENS LATEM, Belgium (BE)
- To:
Publication
Bulletin
1
- Bulletin heading:
- SPC
- Journal edition number:
- 2018/15
- Publication date:
- 24/08/2018
- Description:
- Contains data concerning applications for- or granted Supplementary Protection Certificates
2
- Bulletin heading:
- SPC
- Journal edition number:
- 2023/23
- Publication date:
- 10/01/2024
- Description:
- Contains data concerning applications for- or granted Supplementary Protection Certificates
3
- Bulletin heading:
- SPC
- Journal edition number:
- 2024/14
- Publication date:
- 05/08/2024
- Description:
- Contains data concerning applications for- or granted Supplementary Protection Certificates
Deed
Change of owner(s)
- Change Kind / Decision Type:
- Other
- Deed number:
- RC2016000604A
- Registration date:
- 15/06/2016
- License effective date:
- License expiration date:
- Scope of license:
- Deed filer:
- DE CLERCQ & PARTNERS CV
- Bulletin edition number:
- Text:
- changement d'adresse
- Country code:
- Updated license number:
- Terminated license number:
Removed pledgee
- Name:
- Address:
Changed pledgee
- Name:
- Address:
Removed usufructuary
- Name:
- Address:
Added usufructuary
- Name:
- Address:
Changed usufructuary
- Name:
- Address:
Annual fee
- Annual fee(s) Due Date:
- 31/07/2026
- Annual fee number:
- 23
- Annual fee amount:
- 750 Euro
- Expected payer:
- Last annual fee payment date:
- 19/06/2025
- Last annual fee paid number:
- 22
- Last annual fee paid amount:
- 700 Euro
- Payer:
- C.P.A.
| Filing date | Document type | Publication Type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|---|
| 15/06/2016 | General Document | Other | 2 | /7/2/0/4/1/0300014027/docs/2014c027_0_generaldocument_20160621_034237231.pdf | |||
| 14/12/2023 | Publication | I2 | 1 | /7/2/0/4/1/0300014027/docs/2014c027_1_i2document_20231214_105526805.pdf | |||
| 14/12/2023 | Outgoing Correspondence | 2 | /7/2/0/4/1/0300014027/docs/2014c027_2_outgoingcorrespondence_20231220_100156409.pdf | ||||
| 15/06/2016 | Request For Change | Letter and/or Form requesting a change in the Register | 1 | /7/2/0/4/1/0300014027/docs/2014c027_3_rfc_20160621_034139813.pdf | |||
| 15/06/2016 | General Document | Other | 2 | /7/2/0/4/1/0300014027/docs/2014c027_4_generaldocument_20160621_034209325.pdf | |||
| 08/06/2018 | Publication | I1 | 1 | /7/2/0/4/1/0300014027/docs/2014c027_5_i1document_20180608_150159797.pdf | |||
| 25/03/2026 | Marketing Authorization | 1st Paediatric Marketing Authorization (EU) | 3 | /7/2/0/4/1/0300014027/docs/2014c027_6_marketingauthorization_20260326_084553014.pdf | |||
| 25/03/2026 | Paediatric Investigation Plan | Paediatric Investigation Plan (PIP) | 1 | /7/2/0/4/1/0300014027/docs/2014c027_7_paediatricinvestigationplan_20260326_084553175.pdf | |||
| 25/03/2026 | Application Form | 6 | /7/2/0/4/1/0300014027/docs/2014c027_8_applicationform_20260326_084554153.pdf | ||||
| 25/03/2026 | General Document | Other | 12 | /7/2/0/4/1/0300014027/docs/2014c027_9_generaldocument_20260326_084553477.pdf | |||
| 25/03/2026 | General Document | Other | 3 | /7/2/0/4/1/0300014027/docs/2014c027_10_generaldocument_20260326_084553827.pdf | |||
| 25/03/2026 | General Document | Other | 52 | /7/2/0/4/1/0300014027/docs/2014c027_11_generaldocument_20260326_084553589.pdf | |||
| 25/03/2026 | General Document | Other | 3 | /7/2/0/4/1/0300014027/docs/2014c027_12_generaldocument_20260326_084553957.pdf | |||
| 26/03/2026 | Publication | I1E | 1 | /7/2/0/4/1/0300014027/docs/2014c027_13_i1edocument_20260326_155650286.pdf |